Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSGZ.L Regulatory News (SGZ)

  • There is currently no data for SGZ

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appendix 3B - New issue announcement

17 Sep 2010 07:00

RNS Number : 8426S
Scotgold Resources Ltd
17 September 2010
 



 

 

 

Scotgold Resources Limited ("Scotgold" or the "Company")

 

Appendix 3B

 

New issue announcement,

application for quotation of additional securities

and agreement

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005.

 

 

Name of entity

SCOTGOLD RESOURCES LIMITED

 

ABN

42 127 042 773

 

We (the entity) give ASX the following information.

 

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1

+Class of +securities issued or to be issued

 

Ordinary fully paid shares

Options

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

 

29,326,690 ordinary shares

14,663,345 options

 

3

Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

Options exercisable at 8 cents

Options expire 30 April 2012

 

 

 

4

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

 

If the additional securities do not rank equally, please state:

·; the date from which they do

·; the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

·; the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Yes

 

 

 

5

Issue price or consideration

 

$0.035 per Share

 

 

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

 

The proceeds will be used for regional exploration and for general working capital.

 

7

Dates of entering +securities into uncertificated holdings or despatch of certificates

 

 

11 November 2010.

Number

+Class

8

Number and +class of all +securities quoted on ASX (including the securities in clause 2 if applicable)

 

 

 

146,633,452

 

 

14,663,345

 

Ordinary Fully Paid Shares (SGZ)

 

Options exercisable at 8 cents each on or before 30 April 2012

 

 

 

Number

+Class

9

Number and +class of all +securities not quoted on ASX (including the securities in clause 2 if applicable)

 

 

 

10

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

No plans to pay dividends at this stage

 

 

Part 2 ‑ Bonus issue or pro rata issue

 

11

Is security holder approval required?

 

No

12

Is the issue renounceable or non-renounceable?

Non-renounceable

13

Ratio in which the +securities will be offered

1:4

14

+Class of +securities to which the offer relates

Ordinary Shares and Options

15

+Record date to determine entitlements

28 September 2010

 

16

Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?

Yes

17

Policy for deciding entitlements in relation to fractions

 

Fractions rounded down

18

Names of countries in which the entity has +security holders who will not be sent new issue documents

Note: Security holders must be told how their entitlements are to be dealt with.

Cross reference: rule 7.7.

None

19

Closing date for receipt of acceptances or renunciations

3 November 2010

20

Names of any underwriters

 

 

None

21

Amount of any underwriting fee or commission

N/A

22

Names of any brokers to the issue

 

 

None

23

Fee or commission payable to the broker to the issue

N/A

24

Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of +security holders

None

25

If the issue is contingent on +security holders' approval, the date of the meeting

No

26

Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled

5 October 2010

27

If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders

N/A

28

Date rights trading will begin (if applicable)

N/A

29

Date rights trading will end (if applicable)

 

 

N/A

30

How do +security holders sell their entitlements in full through a broker?

N/A

31

How do +security holders sell part of their entitlements through a broker and accept for the balance?

N/A

 

32

How do +security holders dispose of their entitlements (except by sale through a broker)?

N/A

33

+Despatch date

 

 

11 November 2010

 

 

 

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

34

Type of securities

(tick one)

 

(a)

X

Securities described in Part 1

 

(b)

All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

Entities that have ticked box 34(a)

  Additional securities forming a new class of securities

 

 

Tick to indicate you are providing the information or documents

 

35

If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders TO BE ADVISED

36

If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over TO BE ADVISED

37

A copy of any trust deed for the additional +securities N/A

 

Quotation agreement

 

1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

 

2 We warrant the following to ASX.

 

·; The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

 

·; There is no reason why those +securities should not be granted +quotation.

 

·; An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

·; Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

 

·; If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

 

 

For further information:

 

United Kingdom:

Scotgold Resources Limited

Westhouse Securities Limited

Bankside Consultants

Chris Sangster (CEO)

Richard Baty / Petre Norton

Simon Rothschild / Oliver Winters

Tel: +44 (0)1838 400 306

Tel: +44 (0)20 7601 6100

Tel +44 (0)20 7367 8888

 

Australia:

Scotgold Resources Limited

Professional Public Relations

Shane Sadleir

(Non-Executive Director)

Karen Oswald

Tel: +61 (8) 9428 2950

Mobile: +61 (0) 411 704 498

Tel: +61 (8) 9388 0944

Mobile: +61 (0) 423 602 353

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFLEAVIRLII
Date   Source Headline
27th Dec 20237:00 amRNSCancellation - Scotgold Resources Limited
24th Nov 202310:09 amRNSAppointment of Administrators
22nd Nov 20237:00 amRNSPlanned Appointment of Administrators
8th Nov 20237:00 amRNSDirector Resignation
7th Nov 20238:00 amRNSPotential Administration Appointment
16th Oct 20237:00 amRNSUpdate On Financing Discussions
2nd Oct 202310:18 amRNSPotential Administration Appointment
29th Sep 20237:00 amRNSCorporate Update
19th Sep 20239:10 amRNSMining Review Update
11th Sep 20237:30 amRNSSuspension - Scotgold Resources Limited
11th Sep 20237:00 amRNSGeological review, mine plan and operations update
10th Jul 20237:00 amRNSProduction, Sales & Operations – Q2 2023 & H1 2023
14th Jun 20237:00 amRNSBoard Appointment
7th Jun 20237:00 amRNSInterim CEO Appointment
1st Jun 20237:00 amRNSOperational Update and Director Resignation
15th May 20237:00 amRNSSubscription and Open Offer GBP2 million raised
26th Apr 20237:00 amRNSPosting of Circular
21st Apr 20237:00 amRNSSubscription & Open Offer to raise £1.5-2.0m
5th Apr 20237:00 amRNSOfftake advance & commencement long hole stoping
31st Mar 20234:35 pmRNSPrice Monitoring Extension
30th Mar 20237:00 amRNSInterim Results
27th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Mar 20232:05 pmRNSSecond Price Monitoring Extn
27th Mar 20232:00 pmRNSPrice Monitoring Extension
27th Mar 202311:06 amRNSSecond Price Monitoring Extn
27th Mar 202311:00 amRNSPrice Monitoring Extension
27th Mar 20239:05 amRNSSecond Price Monitoring Extn
27th Mar 20239:00 amRNSPrice Monitoring Extension
27th Mar 20237:00 amRNSOperations and Corporate Update
16th Feb 20237:00 amRNSResult of Retail Offer - Capital Raising of £3m
10th Feb 202311:05 amRNSSecond Price Monitoring Extn
10th Feb 202311:00 amRNSPrice Monitoring Extension
10th Feb 20239:05 amRNSSecond Price Monitoring Extn
10th Feb 20239:00 amRNSPrice Monitoring Extension
10th Feb 20237:00 amRNSResults of Capital Raise
9th Feb 20235:00 pmRNSRetail Offer
9th Feb 20234:42 pmRNSProposed Capital Raising
7th Feb 20239:00 amRNSPrice Monitoring Extension
31st Jan 20239:05 amRNSSecond Price Monitoring Extn
31st Jan 20239:00 amRNSPrice Monitoring Extension
30th Jan 20239:05 amRNSSecond Price Monitoring Extn
30th Jan 20239:00 amRNSPrice Monitoring Extension
20th Jan 20232:05 pmRNSSecond Price Monitoring Extn
20th Jan 20232:00 pmRNSPrice Monitoring Extension
19th Jan 20232:15 pmRNSResults of 2022 Annual General Meeting
19th Jan 20237:00 amRNSQ4 2022 Results and 2023 Outlook
29th Dec 20221:00 pmRNSNotice of AGM
21st Dec 20227:00 amRNSPre-close Q4 2022 – Production Update
21st Dec 20227:00 amRNSFinal Results
19th Dec 20227:00 amRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.